[SKYSTAR COMMENCES TESTING ON TWO ADDITIONAL NEW PRODUCT DOSAGE FORMS TO FURTHER EXPAND THE COMPANY’S PRODUCT LINES The new dosage forms projected to generate $5 million in additional revenue by fiscal 2011 XI'AN, CHINA – May 12, 2010 - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), The product testing process will ensure that the new dosage forms will adhere]
[Home Inns Reports First Quarter 2010 Financial Results Revenues Increased 28% Year over Year to RMB 683 Million Shanghai, May 11, 2010 First Quarter 2010 Financial Highlights Total revenues for the first quarter increased 28.3% year over year to RMB 682.9 million (US$100.0 million), exceeding the guidance range of RMB 650 million to RMB 670 million. Net]
[Home Inns Reports First Quarter 2010 Financial Results Revenues Increased 28% Year over Year to RMB 683 Million Shanghai, May 11, 2010 First Quarter 2010 Financial Highlights Total revenues for the first quarter increased 28.3% year over year to RMB 682.9 million (US$100.0 million), exceeding the guidance range of RMB 650 million to RMB 670 million. Net]
[Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET XIANYANG, China, May 12, 2010 (Xinhua-PRNewswire-FirstCall) http://www.viavid.net http://viavid.net/dce.aspx?sid=00007582 http://www.microsoft.com/windows/windowsmedia/en/download/default.asp This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at About Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary]
[Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET XIANYANG, China, May 12, 2010 (Xinhua-PRNewswire-FirstCall) http://www.viavid.net http://viavid.net/dce.aspx?sid=00007582 http://www.microsoft.com/windows/windowsmedia/en/download/default.asp This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at About Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary]
[SKYSTAR COMMENCES TESTING ON TWO ADDITIONAL NEW PRODUCT DOSAGE FORMS TO FURTHER EXPAND THE COMPANY’S PRODUCT LINES The new dosage forms projected to generate $5 million in additional revenue by fiscal 2011 XI'AN, CHINA – May 12, 2010 - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), The product testing process will ensure that the new dosage forms will adhere]
[] [I, Jie Han, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification of Principal Financial Officer I, Taylor Zhang, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Taylor Zhang, Principal Financial and Accounting Officer]
[] [I, Jie Han, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification of Principal Financial Officer I, Taylor Zhang, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Taylor Zhang, Principal Financial and Accounting Officer]
[ReneSola Ltd Announces First Quarter 2010 Results Company returns to profitability with net income of US$11.8 million; Achieves revenues of US$206.6 million and record quarterly shipments of 242.4 MW, both exceeding Company guidance JIASHAN, China, May 10, 2010 “ ” First Quarter 2010 Financial and Operating Highlights · Total solar product shipments in Q1 2010 were a record 242.4 megawatts] [RENESOLA LTD No. 8 Baoqun Road, YaoZhuang Jiashan, Zhejiang 314117 People’s Republic of China x ¨ Form 20-F ¨ x Yes N/A 82- ____ RENESOLA LTD Xianshou Li Xianshou Li Chief Executive Officer]
[ReneSola Ltd Announces First Quarter 2010 Results Company returns to profitability with net income of US$11.8 million; Achieves revenues of US$206.6 million and record quarterly shipments of 242.4 MW, both exceeding Company guidance JIASHAN, China, May 10, 2010 “ ” First Quarter 2010 Financial and Operating Highlights · Total solar product shipments in Q1 2010 were a record 242.4 megawatts] [RENESOLA LTD No. 8 Baoqun Road, YaoZhuang Jiashan, Zhejiang 314117 People’s Republic of China x ¨ Form 20-F ¨ x Yes N/A 82- ____ RENESOLA LTD Xianshou Li Xianshou Li Chief Executive Officer]
